Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy

British Journal of Surgery

Volumn 104, Issue 3, 2017, Pages 222-229

  Balvers, K ^a   van Dieren, S ^a   Baksaas Aasen, K ^b   Gaarder, C ^b   Brohi, K ^c   Eaglestone, S ^c   Stanworth, S ^d   Johansson, P I ^e   Ostrowski, S R ^e   Stensballe, J ^e   Maegele, M ^f   Goslings, J C ^a   Juffermans, N P ^a   Bergman, R ^g   Naess, P A ^g   Kolstadbraten K M ^g   Rourke, C ^g   Gall, L ^g   Curry, N ^g   Sturmer E K ^g   Schafer N ^g   Driessen, A ^g   Orr, A ^g   Schubert, A ^g   Gorlinger K ^g   Harrison, M ^g   Buchanan, J ^g   Char, A ^g   Neble, S ^g   Sayel, H ^g   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF WITTEN HERDECKE   (Germany)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRINOGEN; HEMOSTATIC AGENT; TRANEXAMIC ACID;

ADULT; AGED; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPLICATION; FEMALE; HUMAN; INJURY; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROCEDURES; PROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; FEMALE; FIBRINOGEN; HEMORRHAGE; HEMOSTATICS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 85009476925     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10330     Document Type: Article

References (33)

1. Haagsma JA, Graetz N, Bolliger I, Naghavi M, Higashi H, Mullany EC et al. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev 2016; 22: 3–18.
2. US Centers for Disease Control and Prevention. Injury Prevention and Control: Data & Statistics (WISQARS™); 2012. https://www.cdc.gov/injury/wisqars/ [accessed 8 July 2016].
3. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54: 1127–1130.
4. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55: 39–44.
5. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652–2658.
6. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805–813.
7. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148: 127–136.
8. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM et al. Transfusion of plasma, platelets, and red blood cells in a 1 : 1 : 1 vs a 1 : 1 : 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313: 471–482.
9. Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG et al. Increased platelet : RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011; 71(Suppl 3): S318–S328.
10. Johansson PI, Oliveri RS, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. J Emerg Trauma Shock 2012; 5: 120–125.
11. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307–310.
12. Stanworth SJ, Davenport R, Curry N, Seeney F, Eaglestone S, Edwards A et al. Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice. Br J Surg 2016; 103: 357–365.
13. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769–773.
14. Fries D. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 2013; 53(Suppl 1): 91s–95s.
15. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64(Suppl): S79–S85.
16. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147: 113–119.
17. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg 2013; 148: 218–225.
18. Porta CR, Nelson D, McVay D, Salgar S, Eckert M, Izenberg S et al. The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis. J Trauma Acute Care Surg 2013; 75: 954–960.
19. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23–32.
20. Cole E, Davenport R, Willett K, Brohi K. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg 2015; 261: 390–394.
21. Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA et al. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg 2013; 75(Suppl 1): S31–S39.
22. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76.
23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007;18: 800–804.
24. Schafer N, Driessen A, Frohlich M, Sturmer EK, Maegele M. Diversity in clinical management and protocols for the treatment of major bleeding trauma patients across European level I trauma centres. Scand J Trauma Resusc Emerg Med 2015; 23: 74.
25. Perkins JG, Cap AP, Spinella PC, Blackbourne LH, Grathwohl KW, Repine TB et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66(Suppl): S77–S84.
26. ®. http://www.anesthesia.at/zlbbehring/929395_F_FI_07-02-15_Haemocomplettan%20CSL%20Behring.pdf [accessed 23 December 2015].
27. McCully SP, Fabricant LJ, Kunio NR, Groat TL, Watson KM, Differding JA et al. The international normalized ratio overestimates coagulopathy in stable trauma and surgical patients. J Trauma Acute Care Surg 2013; 75: 947–953.
28. ®) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108: 36–41.
29. Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care 2015; 19: 97.
30. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256: 476–486.
31. Hsu JM, Hitos K, Fletcher JP. Identifying the bleeding trauma patient: predictive factors for massive transfusion in an Australasian trauma population. J Trauma Acute Care Surg 2013; 75: 359–364.
32. Callcut RA, Cotton BA, Muskat P, Fox EE, Wade CE, Holcomb JB et al. Defining when to initiate massive transfusion: a validation study of individual massive transfusion triggers in PROMMTT patients. J Trauma Acute Care Surg 2013; 74: 59–65, 67–68.
33. Goodman MD, Makley AT, Hanseman DJ, Pritts TA, Robinson BR. All the bang without the bucks: defining essential point-of-care testing for traumatic coagulopathy. J Trauma Acute Care Surg 2015; 79: 117–124.